John Knorpp - Merit Medical Chief Officer
| MMSI Stock | USD 105.03 0.95 0.91% |
Insider
John Knorpp is Chief Officer of Merit Medical Systems
| Address | 1600 West Merit Parkway, South Jordan, UT, United States, 84095 |
| Phone | 801 253 1600 |
| Web | https://www.merit.com |
Merit Medical Management Efficiency
The company has return on total asset (ROA) of 0.0456 % which means that it generated a profit of $0.0456 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.094 %, meaning that it created $0.094 on every $100 dollars invested by stockholders. Merit Medical's management efficiency ratios could be used to measure how well Merit Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Merit Medical's Return On Capital Employed is increasing as compared to previous years. The Merit Medical's current Return On Assets is estimated to increase to 0.05, while Return On Tangible Assets are projected to decrease to 0.05. As of now, Merit Medical's Total Current Assets are increasing as compared to previous years. The Merit Medical's current Intangible Assets is estimated to increase to about 342.2 M, while Other Assets are projected to decrease to under 25.7 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Arthur Cummings | Alcon AG | 57 | |
| Candace Matthews | AptarGroup | 61 | |
| Michael Onuscheck | Alcon AG | 53 | |
| Thomas Glanzmann | Alcon AG | 61 | |
| Mischa Reis | Envista Holdings Corp | 52 | |
| James Winters | Teleflex Incorporated | 48 | |
| Isabel MareySemper | AptarGroup | 53 | |
| Juan Arbona | Envista Holdings Corp | N/A | |
| Dieter Spalti | Alcon AG | 58 | |
| Cord Staehler | Dentsply Sirona | 54 | |
| F Ball | Alcon AG | 64 | |
| Amy Wakeham | ResMed Inc | N/A | |
| Mark Nance | Envista Holdings Corp | 56 | |
| Ines Poschel | Alcon AG | 50 | |
| Rajwant Sodhi | ResMed Inc | 46 | |
| Teresa Madden | The Cooper Companies, | 65 | |
| Richard Luzzi | West Pharmaceutical Services | 72 | |
| Francis Tan | Haemonetics | N/A | |
| B Owens | AptarGroup | 66 | |
| Gerard III | The Cooper Companies, | 59 | |
| Kieran Gallahue | Envista Holdings Corp | 57 | |
Management Performance
| Return On Equity | 0.094 | ||||
| Return On Asset | 0.0456 |
Merit Medical Systems Leadership Team
Elected by the shareholders, the Merit Medical's board of directors comprises two types of representatives: Merit Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merit. The board's role is to monitor Merit Medical's management team and ensure that shareholders' interests are well served. Merit Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merit Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fred Lampropoulos, Chairman, CEO and Pres | ||
| CPA Parra, CFO Treasurer | ||
| Sarah Comstock, Vice Communications | ||
| JoAnne Alkire, Executive Strategy | ||
| Joseph Wright, President - International Division | ||
| Neil Peterson, Chief Officer | ||
| Joseph Pierce, Chief Officer | ||
| Nicole Priest, Chief Officer | ||
| Michel Voigt, Chief Officer | ||
| Brian Lloyd, Chief Legal Officer, Corporate Secretary | ||
| Ricardo Alvarez, Managing Tijuana | ||
| John Knorpp, Chief Officer | ||
| Jason Treft, Chief Officer | ||
| Brian JD, Chief Secretary |
Merit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merit Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.094 | ||||
| Return On Asset | 0.0456 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 6.36 B | ||||
| Shares Outstanding | 58.28 M | ||||
| Shares Owned By Insiders | 2.47 % | ||||
| Shares Owned By Institutions | 97.53 % | ||||
| Number Of Shares Shorted | 2.69 M | ||||
| Price To Earning | 956.67 X |
Currently Active Assets on Macroaxis
When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Earnings Share 2.05 | Revenue Per Share 22.847 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0456 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.